Experimental meningococcal septicemia. Effect of heparin therapy

Area of Science:

• Microbiology
• Pathology
• Pharmacology

Background:

• Meningococcal septicemia is a severe infection with high mortality.
• The underlying mechanisms of disease progression and potential therapeutic interventions require further investigation.

Purpose of the Study:

• To investigate the pathogenesis of experimental meningococcal septicemia in rabbits.
• To evaluate the efficacy of heparin sodium therapy in treating this condition.

Main Methods:

• Rabbits were inoculated with type B *Neisseria meningitidis* in mucin to induce septicemia.
• Clinical signs, hematological parameters, and pathological changes were monitored.
• Heparin sodium was administered as a pretreatment to assess its therapeutic effect.

Main Results:

• Infection led to mortality in 50% of rabbits, characterized by respiratory distress and circulatory failure.
• Pathological findings included diffuse pulmonary capillary and venular thrombosis and renal glomerular fibrin deposition.
• Hematological changes observed were decreased platelet and leukocyte counts, decreased plasma fibrinogen, and prolonged clotting times.
• Heparin sodium reduced intravascular fibrin deposition but did not prevent pulmonary microthrombi, mortality, or improve survival time.

Conclusions:

• Widespread thrombosis of the pulmonary microcirculation is the primary cause of death in experimental meningococcal septicemia.
• Diffuse intravascular coagulation complicates the disease and can be managed with heparin sodium, though it is not the immediate cause of death.